✦ LIBER ✦

511 POSTER Phase I study of IMC-3G3, an IgG1 monoclonal antibody targeting platelet-derived growth factor alpha (PDGFRa) in patients with advanced solid malignancies

✍ Scribed by E. Chiorean; C. Sweeney; H. Youssoufian; F. Fox; T. Katz; E. Rowinsky; R. Amato

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of olaratumab, an anti-p

✍ Chiorean, E. Gabriela; Sweeney, Christopher; Youssoufian, Hagop; Qin, Amy; Donta 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 529 KB

554 POSTER Pharmacokinetic (PK) and phar

✍ M.L. Rothenberg; E. Poplin; P. LoRusso; E. Yu; J. Schwartz; F. Fox; J. Mehnert; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

406 POSTER IMC-18F1, a recombinant human

✍ S. Krishnamurthi; P.H.B. Goncalves; F. Fox; N. Hall; E. Rowinsky; J. Schwartz; H 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 81 KB

648 POSTER A phase I dose-escalation stu

✍ C. Higano; M. Gordon; P. LoRusso; F. Fox; T. Katz; J. Roecker; E. Rowinsky; H. Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

647 POSTER A phase I dose-escalation stu

✍ R. Cohen; D. Camidge; S. Diab; L. Gore; L. Chow; C. O'Bryant; E. Temmer; F. Fox; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A phase I pharmacokinetic (PK) and seria

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 256 KB